Indication
Attention Deficit Hyperactivity Disorder (ADHD)
1 clinical trial
1 product
1 drug
Clinical trial
Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)Status: Not yet recruiting, Estimated PCD: 2025-11-01
Product
Guanfacine HydrochlorideDrug
Varlilumab